Capecitabine 500mg
| Product Overview | |
| Generic Name | Capecitabine 500mg |
| Brand Name(s) | XELODA® |
| Form | 120 Oral Tablets |
| Strength | 500 mg |
| Therapeutic Class | Antimetabolite / pyrimidine analogue |
| ATC Code | L01BC06 |
| Manufacturing & Regulatory | |
| Manufacturer | Originator Genentech, Roche |
| Country | USA, India |
| GMP Compliance | WHO-GMP |
| COFEPRIS | 010.000.5461.00 |
| Free Sale Certificate | Yes, available as COPP/CPP |
| Logistics & Export | |
| MOQ | 10 pks |
| Shelf Life | 24 Months |
| Storage | Controlled room temperature 20–25 °C |
| Incoterms | EXW, 30049049 |
| Lead Time | 7 - 10 Business Days |
| Documentation | |
| Certificate of Analysis (COA) | Yes, typically available as a lot/batch CoA |
| CTD Summary | Not publicly available as parallel traded molecule |
Description
Capecitabine is an oral fluoropyrimidine used in oncology regimens, including colorectal cancer and breast cancer, and in combination regimens for certain gastrointestinal cancers.
